Mir Basir, DO
Interventional Cardiology · Detroit, MINPI 1326369695
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $280,585 of the $442,043 with a category attached, or 63.5%. 20 manufacturers reported payments, led by Abiomed at 52.6% of the total. Among interventional cardiology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 353 payments — averaging $1252.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$232K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$67K
- Saranas, Inc.$61K
- ZOLL Circulation Inc$22K
- Chiesi USA, Inc.$22K
- Boston Scientific$20K
- plus $19K from 14 others
Across 58 payments — averaging $5670.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- ZOLL Circulation Inc$186K
- Chiesi USA, Inc.$143K
What the payments were for
- Consulting fees$118,88527%
- Speaking & faculty fees$280,58563%
- Travel & lodging$34,0108%
- Food & beverage$8,5632%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 165 | $232,441 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 51 | $67,020 |
| Saranas, Inc. | 26 | $60,504 |
| ZOLL Circulation Inc | 15 | $22,036 |
| Chiesi USA, Inc. | 16 | $21,577 |
| Boston Scientific | 34 | $19,833 |
| Abbott | 14 | $8,327 |
| Magenta Medical Inc | 6 | $5,736 |
| Cardiovascular Systems Inc. | 4 | $3,653 |
| Procyrion, Inc. | 4 | $303 |
| Livanova USA, Inc. | 1 | $133 |
| Stryker | 1 | $117 |
| Philips North America LLC | 2 | $92 |
| Amgen | 6 | $84 |
| Teleflex LLC | 2 | $56 |
| Medtronic | 1 | $49 |
| Cordis US CORP. | 2 | $30 |
| Cardinal Health 200 LLC | 1 | $27 |
| Getinge USA Sales, LLC | 1 | $14 |
| Shockwave Medical, Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$202,638
- LifeVest$66,731
- TherOx DS2 Console$22,006
- Catheter$22,006
- Downstream Cartridge$22,006
- KENGREAL$17,809
- GENERAL VASCULAR ACCESS$12,159
- Perclose ProGlide suture mediated closure system$4,050
- Xience V coronary stent system$3,860
- Coronary Orbital Atherectomy System$3,600
- GENERAL - STRUCTURAL HEART$196
- AORTIX SYSTEM$163
- Emerge Push$145
- LifeSPARC$133
- FlowTriever$117
- Sentinel$112
- GENERAL - THERAPIES$107
- HeartMate 3 Left Ventricular Dev$103
How this compares
$442,043 in reported general payments places this provider in the 95th percentile of 187 interventional cardiology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 91 | $113,767 |
| EliquisApixaban | 48 | $56,840 |
| EntrestoSacubitril/Valsartan | 22 | $27,727 |
| FarxigaDapagliflozin Propanediol | 24 | $24,747 |
| Repatha SureclickEvolocumab | 24 | $18,019 |
| BrilintaTicagrelor | 12 | $8,605 |
| Praluent PenAlirocumab | 11 | $4,817 |
| Atorvastatin Calcium | 158 | $2,227 |
| Metoprolol Succinate | 104 | $1,482 |
| Carvedilol | 80 | $1,140 |
| Losartan Potassium | 79 | $1,106 |
| ClopidogrelClopidogrel Bisulfate | 66 | $1,073 |
| Spironolactone | 93 | $979 |
| Bumetanide | 16 | $868 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 33 | $710 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Detroit
- Amir KakiDetroit$1.8M
- Tamam MohamadDetroit$960K
- Khaldoon AlaswadDetroit$276K
- M Chadi AlraiesDetroit$216K
- Zaher HakimDetroit$92K
- Delair GardiDetroit$63K
- Brittany FullerDetroit$61K
- Paul GrossmanAnn Arbor$630K
- Jason RicciPetoskey$594K
- Tim FischellKalamazoo$468K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.